Cat. No.: 119-2P
Amount: 100 µg
Price:
$110.00
|
|
|
| Cat. No. 119-2P |
100 µg peptide, lyophilized. For reconstitution add 100 µl H2O to get a 1mg/ml solution in PBS. Then aliquot and store at -20°C to -80°C until use. Control peptides should be stored at -20°C when still lyophilized! |
| Applications |
|
| Immunogen | Synthetic peptide corresponding to AA 2 to 16 from rat SV2C (UniProt Id: Q9Z2I6) |
| Recommended dilution | Optimal concentrations should be determined by the end-user. |
| Matching antibodies | 119 202, 119 203, 119 204 |
| Remarks |
This control peptide consists of the synthetic peptide (aa 2-16 of rat SV2 C) that has been used for immunization. It has been tested in preadsorption experiments and blocks efficiently and specifically the corresponding signal in Western blots. The amount of peptide needed for efficient blocking depends on the titer and on the affinity of the antibody to the antigen. |
| Data sheet | 119-2p.pdf |
|
|
SV2s (Synaptic Vesicle Protein 2) are integral membrane glycoproteins present in synaptic vesicles. They have 12 transmembrane domains predicted by sequence analysis (1). There are three characterized isoforms, SV2 A, SV2 B and SV2 C that are similar in structure but show different expression patterns. SV2 A is expressed ubiquitously throughout the brain and plays a crucial role in modulating synaptic transmission by regulating the expression and trafficking of synaptotagmin, a key calcium sensor in neurotransmitter release (1).
SV2 B has a more restricted distribution with varying degrees of coexpression with SV2 A and is predominantly found in the cortex and hippocampus (2). SV2 C is more closely related to SV2 A but shows a very restricted expression pattern. The highest expression levels were observed in phylogenetically old brain areas like pallidum, the midbrain and the olfactory bulb (3).
SV2 expression has also been observed in other non-neuronal organs. In kidney it localizes to podocytes and is essential for the integrity of the glomerular filtration barrier (4).